Ptc Therapeutics (PTCT) Interest Coverage Ratio (2012 - 2026)

Ptc Therapeutics' Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 0.29 for Q1 2026.

• On a quarterly basis, Interest Coverage Ratio fell 98.47% year-over-year to 0.29 in Q1 2026; TTM through Mar 2026 was 0.38, a 111.25% decrease from a year earlier, with the FY2025 full-year figure at 1.06, up 400.95% from the prior year.
• Interest Coverage Ratio advanced to 0.29 in Q1 2026 per PTCT's latest filing, from 0.43 in the prior quarter.
• Across five years, Interest Coverage Ratio topped out at 46.82 in Q4 2022 and bottomed at 14.11 in Q1 2022.
• The 5-year median for Interest Coverage Ratio is 0.74 (2024), against an average of 1.03.
• Across the five-year window, Interest Coverage Ratio plunged 1927.31% in 2023 and surged 2252.74% in 2025, its largest moves.
• Year by year, Interest Coverage Ratio stood at 46.82 in 2022, then tumbled by 98.45% to 0.72 in 2023, then tumbled by 514.72% to 3.0 in 2024, then soared by 85.77% to 0.43 in 2025, then soared by 167.73% to 0.29 in 2026.
• Per Business Quant, the three latest PTCT Interest Coverage Ratio figures stand at 0.29 (Q1 2026), 0.43 (Q4 2025), and 0.02 (Q3 2025).